Which of the following agents is known to potentially trigger malignant hyperthermia in genetically susceptible individuals?

Choice A rationale This depolarizing neuromuscular blocking agent is a primary pharmacological trigger for malignant hyperthermia in individuals with an underlying ryanodine receptor mutation. The drug causes a massive and uncontrolled release of calcium from the sarcoplasmic reticulum into the skeletal muscle cytoplasm. This intracellular calcium surge leads to sustained muscle contractions, a hypermetabolic state, excessive heat production, and severe respiratory and metabolic acidosis, which can be fatal if the triggering agent is not immediately discontinued. Choice B rationale Modern local anesthetics such as lidocaine, bupivacaine, and ropivacaine are considered safe and do not trigger malignant hyperthermia. Historically, there was confusion regarding their safety, but extensive clinical research has confirmed they do not interact with the calcium release channels in skeletal muscle. These agents work by blocking sodium channels along nerve fibers to prevent the conduction of pain impulses and are widely used in various surgical procedures without risk of inducing a hypermetabolic crisis. Choice C rationale While nitrous oxide is a common inhalational anesthetic gas used for induction and maintenance of anesthesia, it is not classified as a triggering agent for malignant hyperthermia. The primary triggers are volatile halogenated inhalational anesthetics such as halothane, sevoflurane, and desflurane. Nitrous oxide can be safely administered to susceptible individuals as part of a total intravenous anesthesia or a non-triggering gas technique, as it does not affect the ryanodine receptors or muscle calcium homeostasis. Choice D rationale This medication is the specific antidote and gold-standard treatment for a malignant hyperthermia crisis rather than a trigger. It works as a skeletal muscle relaxant by directly binding to ryanodine receptors and inhibiting the release of calcium from the sarcoplasmic reticulum. By restoring normal intracellular calcium levels, it halts the hypermetabolic process, reverses muscle rigidity, and allows the body temperature to normalize. It must be administered rapidly as soon as a crisis is suspected.